Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$15.05
-1.25%
Mkt Cap $5.03B
Analyst Ratings
Buy
3
Hold
4
Sell
0
Price Target (22 analysts)
$22.50
Range $16.00 – $30.00
Implied Upside
+49.5%
Consensus $22.50 vs current $15.05
NASDAQ·Healthcare·Biotechnology
$15.05
-1.25%
Mkt Cap $5.03B
Buy
3
Hold
4
Sell
0
Price Target (22 analysts)
$22.50
Range $16.00 – $30.00
+49.5%
Consensus $22.50 vs current $15.05